Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III ...

Genentech will close its cancer immunology research department, and unit head and renowned cell biologist Ira Mellman, who has been with the company for 17 years, will depart in the coming months.

June 30 (Reuters) - Genentech will withdraw Gavreto from use in the United States for treating a type of thyroid cancer as it was not feasible for the Roche (ROG.S), opens new tab unit to pursue ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall ...

Genentech, where Stanford President Marc Tessier-Lavigne once served as chief scientific officer, confirmed on Thursday that there were concerns about Alzheimer’s research Tessier-Lavigne co ...

How Genentech and other drug makers are stepping up the game in how they interact with patients. As Sawsan Zakaria and other spinal muscular atrophy patients made their way along the fashion show ...

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get ...

You can reach Jonathan on Signal at jwosen.27. For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved ...

Repertoire Immune Medicines has signed a partnership and licensing agreement with Roche’s Genentech, focusing on the discovery and development of T cell-targeted immune medicines for treating an ...

SOUTH SAN FRANCISCO – Biotech firm Genentech will pay more than $150,000 in fines to settle claims of alleged hazardous waste violations at its facility in South San Francisco. The Environmental ...